Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Seven US cancer treatment centres purchase BSD-500 hyperthermia systems

BSD Medical : 03 July, 2008  (Company News)
Seven new BSD Medical BSD-500 hyperthermia systems have been purchased by major cancer treatment centres in the USA.
The most recent purchase by the Massey Cancer Center at Virginia Commonwealth University located in Richmond, Virginia, USA, joins in a number of recent hyperthermia system sales in the USA. Other notable cancer care hospitals that have also purchased or installed BSD hyperthermia systems this year include:

Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, USA

William Beaumont Hospital in Grosse Pointe, Michigan, USA

Robert H Lurie Comprehensive Cancer Center at Northwestern University in Chicago, Illinois, USA

Banner Good Samaritan Medical Center in Phoenix, Arizona, USA

Cancer Treatment Centers of America (CTCA) in Tulsa, Oklahoma, USA

Spectrum Health Blodgett Hospital in Grand Rapids, Michigan, USA

These cancer treatment centers have a long-standing tradition of offering world-class cancer care and treatment in the United States. The addition of hyperthermia therapy to each institution as an adjuvant to traditional cancer treatment demonstrates leadership in cancer awareness, diagnosis and management.

The BSD-500 systems purchased by these cancer institutions are employed to treat various types of cancer. Hyperthermia is used to make cancer cells more sensitive to radiation as well as destroy cancer cells directly. In Phase III clinical trials where hyperthermia was combined with radiation, hyperthermia improved two-year local control of melanoma from 28 to 46 percent, complete response for recurrent breast cancer from 23 to 68 percent and the five-year survival rate from 0 to 53 percent in patients with head and neck cancer, compared to the use of radiation therapy alone.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo